CNSPulse

REGULATORY CHALLENGES: ASK THE EXPERTS

Tiffany Farchione — US Food and Drug Administration Valentina Mantua, Center for Drug Evaluation and Research, Food and Drug Administration Bernard Fischer, U.S. Food and Drug Administration

2026 ASCP Annual Meeting

This session is intended to facilitate dialogue between expert regulators from the US Food and Drug Administration and conference participants with an interest in drug development and clinical research in psychopharmacology. There will be no presubmitted questions, but rather regulators will take questions directly from the audience.

Learning Objective 1: Participants will be able to ask questions to a panel of FDA representatives.

Learning Objective 2: Participants will learn from regulators how to improve quality of clinical research. Poster Session I with Lunch